Specifically, IDO suppresses effector T cell activation by depleting tryptophan and increasing kynurenine production, a process that facilitates the induction and expansion of regulatory T cells, further reinforcing the immunosuppressive milieu and favoring tumor progression [35]. This evidence concerns the gene IDO1 and neoplasm.